Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
After surviving prostate most cancers, Andy Winnegar obtained a analysis of persistent lymphocytic leukemia (CLL) in 2021. Make amends for Andy's blogs right hereThe...
For sufferers with MET exon 14-altered NSCLC, Tepmetko was related to frequent unwanted effects, though the security profile is taken into account manageable.Amongst...
Prostate most cancers therapy continues to evolve, and sufferers have extra choices than ever; nonetheless, understanding the dangers and advantages of every method...
